Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 13, 2026

Dr Reddys Laboratories Ltd shares saw a -0.27% decrease, reaching a current market price of 1271.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.2600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd stock price decreased by -0.27%, with the current market value at 1271.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a -0.41% decrease, reaching a current market price of 1269.70. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.2600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.41% in its share price, and it currently trades at 1269.70 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at 1274.40. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.2600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is now at 1274.40. The stock is currently trading at a PE of 19.2600, while the industry PE is 32.0438, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd stock price decreased by -0.25%, with the current market value at 1271.70 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

With a -0.25% decrease, Dr Reddys Laboratories Ltd's share price is now at 1271.70. The stock is currently trading at a PE of 19.2600, while the industry PE is 32.0438, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.71%, signalling a challenging period. Currently trading at 1265.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd share price has declined by -0.71%, and it's currently trading at 1265.80. The stock maintains a PE of 19.2600, while the industry PE is 32.0438, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.27% dip in its share price and is currently trading at 1271.40. The stock has a PE ratio of 19.2600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

After a -0.27% decline, Dr Reddys Laboratories Ltd shares are now trading at 1271.40. The stock has a PE ratio of 19.2600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.